The DNA of Things with Dr. Jeremy Koenig

From the fast-paced trading floors of Wall Street to the cutting edge of molecular diagnostics, James York's career path is anything but conventional — and that's exactly what makes his work so powerful. As Chief Commercial Officer at Molecular Testing Labs, James has spent over a decade quietly dismantling one of healthcare's most persistent problems: access. In this episode of The DNA of Things, Dr. Jeremy Koenig sits down with James to unpack how at-home sample collection, self-directed testing, and the convergence of genomics, biomarker data, and AI are reshaping what it means to take ownership of your health. Whether you're a clinician, a digital health builder, or someone who's simply tired of waiting for the system to catch up with your goals, this conversation is a masterclass in why the future of healthcare isn't coming — it's already being built, and it starts with you getting in the game.

🎯 Key Takeaways

• 🧬 Molecular diagnostics are no longer just for clinics — at-home sample collection is making lab-quality testing available to anyone, anywhere
• 🏦 Wall Street to wellness — James's background in market-making directly shaped how he thinks about healthcare access and building new systems from the ground up
• 🚧 The real barrier isn't the test — it's the friction — stigma, geography, and economics are the true gatekeepers MTL is working to remove
• 📊 The three-tool revolution is here — genome sequencing + biomarker testing + AI is the new trifecta for understanding your full health picture
• 💊 Pharmacogenomics is going mainstream — CYP/SIP testing is now being recommended in TV commercials, signaling a massive shift in how personalized medicine is being adopted
• 🏃 Your DNA affects your performance, not just your disease risk — from injury vulnerability in elite athletes to how you metabolize nutrients, your genome is a blueprint for optimization
• 🤝 Molecular Testing Labs is the silent infrastructure behind the scenes — they power the workflows so brands, health platforms, and practitioners don't have to build from scratch
• 🏠 Care is moving home — virtual encounters and at-home diagnostics are converging, and the labs that survive will be the ones that connect seamlessly to that shift
• 🧠 AI won't replace the expert — it scales them — the future belongs to the Mr. Miyagi practitioner who can reach thousands of patients without losing the intimacy of care
• ✅ The #1 takeaway: Get in the game — the tools exist, they're affordable, and they're more accessible than ever — curiosity is the only thing standing between you and your health data

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

What happens when the architect behind one of the world's largest consumer genomics platforms decides to build what comes next? In this episode of The DNA of Things, Dr. Jeremy Koenig sits down with Mike Polcari — former Chief Architect at 23andMe and now founder of Haplotype Labs — to talk about what the $100 genome actually unlocks, why genetics has been stuck in research labs for too long, and how a new infrastructure layer could finally bring polygenic risk scores into everyday clinical care.

If you've ever wondered why your DNA report sits in a PDF collecting digital dust instead of actively guiding your health decisions in real time, this conversation is for you.

Connect with Mike: https://www.haplotypelabs.com/contact

Key Takeaways

🧬 The genome is no longer expensive — interpretation is the bottleneck. Sequencing just crossed $100, but having data and knowing what to do with it are two very different things. Mike estimates we're still about five years from fully understanding an individual's germline genetics.

🔬 Polygenic risk scores make genomics useful for everyone. Most people won't carry a dramatic single variant. PRS aggregates thousands of small signals to give meaningful risk predictions for things like heart disease and cancer — making DNA actionable for the masses, not just edge cases.

🏗️ Haplo Hub eliminates the infrastructure tax. Building a genomics pipeline used to mean 18 months of engineering and millions spent before offering a single DNA insight. The Hub lets any lab or health brand go from raw data to validated risk scores via a clean API — no bioinformatics team required.

🤖 AI chatbots can't replace validated genomic models. Ask ChatGPT for a PRS score and it'll confidently give you a wrong answer. Mike's vision is your omics data living in a secure, continuously updated cloud that health AI platforms can actually query accurately.

📡 Your DNA should follow you — not stay locked with whoever sequenced you first. The personal omics cloud means your genome gets reinterpreted as science improves and integrates contextually into every health decision you make.

🌐 Telehealth legitimization opened the market. COVID forced mainstream adoption of telehealth, creating national-scale infrastructure for preventative health services — exactly the kind that can finally incorporate genomics into care at scale.

🔓 Open science needs a commercial on-ramp. Researchers publish better genomic models every month. Most never reach a clinic. Haplo Hub closes that 15-year translation gap.

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

In this episode, Dr. Jeremy Koenig talks with biotech leader Vijay Vaswani, co-founder and CEO of Omniscope, about how decoding the immune system at single-cell resolution is changing how we define true health and extend healthspan.

✨ Key takeaways

🧠 True age vs birthday age: Your “real” age is your immune age, and elite athletes and centenarians often have surprisingly youthful immune profiles.
🧬 From fuzzy maps to HD biology: High-resolution immune sequencing replaces low-resolution lab tests with a much more detailed view of how cells drive health and disease.
🏃‍♂️ Athletes as health models: Profiling the immune systems of pro athletes reveals what low-inflammation, high-performance biology looks like in practice.
🤖 Immune GPT & cellular avatars: Omniscope’s immune-focused AI and “cellular avatars” help design new drugs, personalize immunotherapies, and give people agency over their biology.
❤️ From sick care to healthspan: Longitudinal immune profiling (OS Lifetime) monitors immune age, inflammation, and resilience to shift medicine toward prevention and extended healthspan.

Episode Overview:

In this episode, Dr. Jeremy Koenig sits down with biotech leader Vijay Vaswani, co-founder and CEO of Omniscope, to explore how decoding the immune system at single-cell resolution is reshaping our understanding of true health and aging. They dig into why your “real” age is your immune age, what we can learn from elite athletes and centenarians, and how high-resolution immune maps move us beyond traditional, low-resolution lab tests. The conversation also covers Omniscope’s immune-focused AI, “cellular avatars,” and longitudinal immune profiling platform, and how these tools could power earlier detection, personalized immunotherapies, and a shift from reactive sick care to proactive, healthspan-focused medicine.

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

In this episode of The DNA of Things, Dr. Jeremy Koenig sits down with Dr. Travis McDonough — serial entrepreneur and CEO of Wellnify AI — for one of the most honest conversations about the future of preventative health you'll hear. Travis spent decades inside professional sports, helping build Conduct Technologies into a human performance platform that supported 650+ pro sports organizations and 25 world championships before its 2020 acquisition. Then came the bigger question: what if everyone had access to those same tools? That became Wellnify AI — a platform fusing behavioral science and gamification to build healthy habits at the community level, not just the elite level.

They get into the childhood roots of it all — dyslexia as a competitive advantage, a father's belief as rocket fuel, and sport as the only thing that ever cleared the noise. Travis is refreshingly honest about the entrepreneurial toll: from laying off 25 people after Intel scrapped a chip overnight, to throwing his house keys on the boardroom table to keep his team employed. And then the pivot — bringing tools once reserved for LeBron and Brady to municipalities, school boards, and everyday people across North America, including a landmark partnership with the Healthier Texas Foundation reaching 3,200 organizations.

Takeaways:

🧠 Dyslexia, ADHD, and slow processing forced Travis to think differently — and that became his edge. Pattern recognition, creative problem-solving, and deep listening aren't soft skills, they're the whole game.

💡 The Pygmalion Effect is real — you rise or fall based on the expectations of the people around you. His father's belief in who he could become shaped everything.

🏥 We're living in a healthcare paradox — the most advanced medical technology in history, and we're still witnessing what Travis calls a "self-inflicted serial killing" of our own wellbeing through sedentary behavior, screen addiction, and outdated wellness education.

🏔️ Build fences at the top of the cliff, not more ambulances at the bottom — the trillion-dollar shift in healthcare is moving toward upstream prevention, and Wellnify AI is built entirely around that bet.

🎮 Gamification isn't just for entertainment — Wellnify AI redirects the same mechanics that keep people scrolling toward movement, mindfulness, learning, and community acts of kindness.

🤝 The most-used feature on the platform is the community section — rewarding users for volunteering, donating blood, picking up litter, and supporting local. People want to do good. They just need a structure that makes it stick.

📊 The Community Wellness Score could change how governments measure what actually matters — aggregating individual data into a community-level metric that reveals blind spots and drives smarter public health investment.

📱 Your attention is your life — Travis closes with a direct message to the 19–21 age group: the algorithm doesn't love you back. It's designed to capture, not to care. Knowing that is the first step.

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

In this episode, Dr. Jeremy Koenig sits down with Dr. Quinn Peterson, a Mayo Clinic stem cell biologist, to explore how regenerative medicine could move type 1 diabetes from lifelong management to true biological restoration.​

✨ Key takeaways:

🔥 From lab curiosity to purpose-driven science: how a cancer drug developer pivoted his entire career after his three-year-old daughter was diagnosed with type 1 diabetes, and later two more of his children.​
🧬 Building transplantable islets, not just beta cells: inside the Mayo Clinic program engineering full pancreatic islets from stem cells to restore a person’s own insulin production.​
🧠 Regeneration as the next medical era: why the future is not just fixing defective proteins but replacing missing cells and rejuvenating tissues before disease takes hold.​
🤝 Science with patients at the table: how funders like Breakthrough T1D are forcing a shift toward patient and public involvement in shaping research questions and trial design.​
📊 Data, digital twins, and AI: a candid look at breaking down clinical data silos, using wearables and records “in the wild,” and what that could mean for trials and personalization.​

Episode overview

Dr. Koenig introduces Dr. Quinn Peterson as a stem cell biologist and biomedical engineer at Mayo Clinic leading an islet regeneration program aimed at creating functional, transplantable pancreatic islets from pluripotent stem cells. Rather than simply managing glucose with exogenous insulin, Peterson’s work aims to restore lost biological function by engineering living systems that behave like native human tissue.​

Quinn shares his origin story: a lifelong fascination with how things work, formal training in biochemistry, and early research careers in water contaminants and then chemotherapeutic drug development. The turning point came when his oldest daughter was diagnosed with type 1 diabetes at age three, eventually followed by two of his other children, prompting a deliberate pivot into diabetes research and postdoctoral training with Doug Melton at Harvard.

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

In this episode, Dr. Jeremy sits down with physician-scientist Dr. Helen Messier to unpack how multi-omics, AI, and “upstream medicine” are rewriting the future of healthcare—from managing chronic disease to truly preventing and reversing it.
​

🧠 Key takeaways:

✨ You have more agency over your biology than you’ve been led to believe—your genes load the gun, but your environment, daily choices, and mindset pull (or don’t pull) the trigger.
​
🧬 “Upstream medicine” uses genomics, microbiome, metabolomics, proteomics, and more to find root causes instead of just chasing symptoms, especially in complex chronic conditions like chronic fatigue, IBS, and dysautonomia.
​
📉 The 15–20 year translational gap between research and the clinic is real, but platforms like BioScope.ai are closing it by turning massive, multi-layered data into usable clinical insight for front-line physicians.
​
⚙️ Your body isn’t broken; it’s adapting—traits that once protected us from famine and trauma can become maladaptive in a world of ultra-processed food, chronic stress, social media, and environmental toxins.
​
🏃‍♀️ The same systems thinking used to tune elite athletes’ training—acute vs. chronic load, HRV, recovery—can guide how families manage stress, sleep, and lifestyle across generations.
​
🧩 Mind and body are one system: psycho‑neuro‑immunology, childhood trauma, and epigenetics all shape how disease shows up decades later, and practices like meditation and nervous-system regulation can change gene expression and health trajectories.

👨‍👩‍👧 True precision health is n-of-one: different people with similar genomes can need very different interventions depending on their environment, stressors, exposures, and life goals (performance vs. healthspan vs. longevity).
​
​

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

In this episode, we sit down with leading bioethicist Dr. Insoo Hyun to unpack how ethics, politics, AI, stem cells, and the future of human identity are colliding in real time—from embryo models and gene editing to digital twins and data ownership.

✨ Key takeaways

🧬 How stem cell ethics, cloning, and embryo models really work behind the headlines—and why “the best argument” often loses to political feasibility.

⚖️ Why paying women for egg donation became a global flashpoint, and how one controversial Nature paper helped unlock pivotal advances in genome editing and mitochondrial disease research.

🤖 What “digital twins” mean for medicine, AI, and your health data—and why consent, ownership, and compensation will define the next era of scientific wellness.

🧠 How analytic philosophy (precision, logic, argument) can make sense of messy questions about consciousness, personhood, and transhumanism.

🌱 Why the future belongs to interdisciplinary thinkers who can bridge biology, ethics, AI, law, and policy—and how students like Kristin Lee can prepare for careers we can’t fully imagine yet.

Episode overview

Dr. Jeremy opens by asking whether the real risks in modern science are not rogue technologies, but the quiet assumptions we never question—about stem cells, AI, and biomedical breakthroughs shaped by politics, fear, and convenience. He introduces Dr. Insoo Hyun as a globally respected bioethicist whose work spans stem cell research, human–animal chimeras, brain organoids, embryo models, and the ethics of emerging biotechnologies.

Hyun traces his unlikely path from pre‑med biology at Stanford, to switching into philosophy, to training in analytic ethics at Brown under Dan Brock—just as Dolly the sheep and human embryonic stem cells were transforming the life sciences. That timing pulled him into President Clinton’s bioethics commission, where he first saw how “political feasibility” can override the most rigorous ethical arguments.

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

In this episode, Dr. Jeremy Koenig sits down with David Lefkovits, visionary CEO and co-founder of WellPro AI, to unpack why personalized, preventative healthcare hasn't scaled yet—and what it's going to take to finally get there. They dig into the broken economics of traditional medicine, why "normal" lab values don't always mean healthy, and how AI-powered systems can turn overwhelming data into actionable care plans that actually stick.

🧬 Health isn't a static number—it's a dynamic conversation between hormones, nutrients, and lived experience that most practitioners aren't trained to read

💰 Traditional healthcare thrives on worse outcomes—more encounters, more beds filled, more prescriptions written—while this emerging wellness economy ties revenue directly to results

🔧 The biggest bottleneck isn't the science or the technology—it's the lack of an operating system that can turn insights into digestible, executable care plans

📊 Most practices juggle 5-6 disconnected tools (EHR, scheduling, messaging, membership management) that don't talk to each other, creating operational chaos

🎯 Patient goals and clinical goals aren't the same thing—someone wants more energy and time with their grandkids, not "take testosterone"

🔄 Personalization is an oxymoron to protocols because everyone reacts differently to the same intervention—closed-loop tracking is non-negotiable

⏳ The shift to outcome-based care is mathematically inevitable—costs keep rising, quality keeps dropping, and consumers will eventually migrate to where they get actual results

🚀 WellPro isn't replacing clinicians—it's building a copilot that synthesizes chaotic patient data so practitioners can do what only they can do: see the patterns everyone else misses

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

In this episode, Chris Spears, founder of OrderlyMeds, shares his transformative journey from a catastrophic ICU experience to building a human-centered medication management platform that's revolutionizing personalized healthcare. Chris opens up about his frustrating odyssey through the broken healthcare system, the worst telemedicine experience of his life, and how those challenges sparked the creation of a company that's now serving over 90,000 patients monthly. This conversation explores the intersection of GLP-1 medications, DNA insights, AI-powered health data, and the future of precision medicine—revealing how one person's struggle became a mission to help millions thrive in the second half of life.

Key Takeaways

🏥 The healthcare system's blindness to patient experience created an opportunity for innovation—Chris transformed his worst customer service experience into a solution that now helps 90,000+ people manage their medication journey

💉 GLP-1 medication shortages persist across America despite high demand—even two years later, many pharmacies still run out within days of receiving shipments

🚀 Rapid scaling is possible with the right mission—OrderlyMeds grew from 17 customers in January 2024 to 60,000 monthly active patients by late 2025, adding 6,000-10,000 new patients each month

🧬 DNA markers can predict GLP-1 response—genetic testing helps determine whether these life-changing medications will actually work for you before making the investment

🔬 The future of healthcare is data integration—combining DNA, blood work, gut biome, wearable tech, and clinical data will enable truly personalized medicine at scale

🤖 AI augments rather than replaces healthcare providers—technology can handle 80% of routine analysis, freeing humans to apply clinical judgment and compassion where it matters most

💰 Financial investment drives adherence—cash-pay patients show higher medication compliance than insurance-covered patients, suggesting skin in the game matters for health outcomes

👨‍👩‍👧‍👦 Building with friends and family creates accountability—surrounding yourself with trusted people who believe in your mission strengthens both culture and execution

📱 Nine disconnected health apps create a new data problem—the next challenge is integrating fragmented health information into a single source of truth for consumers

🎯 Personalized medicine requires personalized compounding—the future means your medication formulation will differ from others based on your unique biology

⚡ Testosterone therapy remains stigmatized despite its benefits—only one in eight men who could benefit from testosterone replacement actually pursue it due to ego and shame

🌟 Thriving in the second half of life is the real goal—weight loss and medication management are tools to help people keep up with grandkids, travel with partners, and enjoy life fully

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

In this episode, Jeremy Koenig sits down with Dr. Chadi Nabhan, a physician-scientist, oncologist, and healthcare innovator who stands at the intersection of cancer care, precision medicine, and artificial intelligence. Dr. Nabhan shares his remarkable journey from serving as a key expert witness in the landmark Monsanto Roundup trials to his current role as Chief Medical Officer at Right, where he's revolutionizing clinical trial design through AI. The conversation explores the critical importance of communication in healthcare, the challenges of translating complex science for patients and families, and how innovative technology is shortening the timeline for life-saving treatments to reach those who need them most.

Key Takeaways

🔬 From Courtroom to Page: Dr. Nabhan's book "Toxic Exposure" chronicles his experience as an expert witness in the Monsanto Roundup trials, revealing the science behind glyphosate's link to lymphoma and the drama of corporate litigation

📚 Making Cancer Accessible: "The Cancer Journey" transforms complex oncology into relatable stories, guiding patients and caregivers through every step from diagnosis to treatment while honoring the often-overlooked role of caregivers

⚡ Time is Lives: Clinical trials can take 10-15 years to complete, but even shortening this timeline by 2-3 years could save countless lives by bringing breakthrough therapies to market faster

🎯 The 80% Problem: 80% of clinical trial sites run behind schedule, and 50% enroll zero or one patient—a massive inefficiency that Right is solving through AI-powered site selection

🤖 Digital Twins Revolution: Right creates digital twins of every clinical trial site worldwide, matching protocols to the best-performing locations based on capabilities, patient demographics, investigator experience, and regulatory history

💬 Language as Technology: Effective communication in healthcare means meeting people where they are—if a patient doesn't understand, it's the clinician's responsibility to communicate better, not the patient's failure to comprehend

🎓 The Readiness Score: Just like Olympic athletes need specific fitness for their sport, clinical trial sites have unique readiness profiles for different studies—no single site is best for everything

📖 Fiction Meets Truth: Dr. Nabhan's fourth book ventures into fiction, creating characters inspired by real experiences in academic medicine, demonstrating how storytelling can illuminate deeper truths

🏥 AI and Cancer Care: His upcoming third book explores how artificial intelligence is transforming every aspect of the cancer journey, aiming to demystify AI and help people embrace rather than fear these innovations

👥 Patient Voices Matter: The most powerful perspectives in healthcare innovation come from patient advocates who can bridge the gap between scientific advancement and lived experience

 LINKS:

https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig